Detail of outcome
The main conclusion of the review was that MHRA performs necessary functions and should continue to operate as an executive agency. The review report also contains recommendations to improve performance, governance and efficiency.
This consultation ran from to
Seeks views on the role and performance of the Medicines and Healthcare Products Regulatory Agency (MHRA)
The department reviews its arm’s length bodies once every 3 years.
This triennial (3 yearly) review looks at what the MHRA does and how.
We want to know what you think of the MHRA, including:
- whether the MHRA needs to continue in its current form
- how the MHRA is performing
- whether the MHRA is providing good value